Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023
Period Ending	Dec '23 Dec 31, 2023
Immune-mediated Diseases and Cancer Therapeutics	7.00M

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023
Period Ending	Dec '23 Dec 31, 2023
United States	7.00M